Source: Pharmacy Times articles
The meeting will focus on the basic, preclinical, and clinical aspects of myeloma, including precursor disease, high-risk disease, immunotherapies, novel biomarkers, and more.
Read More
by | Sep 24, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
The meeting will focus on the basic, preclinical, and clinical aspects of myeloma, including precursor disease, high-risk disease, immunotherapies, novel biomarkers, and more.
Read More